Emad Behboudi
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Viral Infections and Vectors 3
- Epidemiology 11
- Hepatitis B Virus Studies 3
- Co-authors
- Hassan Dianat‐Moghadam (2 shared papers)Amir Ghaemi (1 shared paper)Mohsen Nakhaie (5 shared papers)Mohsen Keshavarz (1 shared paper)Seyed Mohammad Miri (1 shared paper)Javad Charostad (6 shared papers)Mohammad Javad Mousavi (2 shared papers)Milad Zandi (3 shared papers)
- Journals
- European Journal of Inflammation (2 papers)Biotechnology and Applied Biochemistry (1 paper)Library Hi Tech (1 paper)Health Care For Women International (1 paper)Advances in Virology (1 paper)
- Partner nations
- IranUnited StatesTürkiye
In The Last Decade
Emad Behboudi
31 papers receiving 200 citations
Peers
Comparison fields: 5 of 61
- Infectious Diseases 61
- Oncology 40
- Genetics 41
- Obstetrics and Gynecology 10
- Immunology 28
Countries citing papers authored by Emad Behboudi
This map shows the geographic impact of Emad Behboudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad Behboudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad Behboudi more than expected).
Fields of papers citing papers by Emad Behboudi
This network shows the impact of papers produced by Emad Behboudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad Behboudi. The network helps show where Emad Behboudi may publish in the future.
Co-authors
The 25 scholars most cited alongside Emad Behboudi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 31 | |
| 2 | 2022 | 22 | |
| 3 | 2022 | 18 | |
| 4 | 2024 | 15 | |
| 5 | 2021 | 12 | |
| 6 | 2024 | 11 | |
| 7 | 2021 | 11 | |
| 8 | 2018 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 3 |
About Emad Behboudi
Emad Behboudi is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Genetics and Public Health, Environmental and Occupational Health, having authored 42 papers that have together received 208 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers), Virus-based gene therapy research (5 papers), Hepatitis B Virus Studies (3 papers), Viral Infections and Vectors (3 papers), Long-Term Effects of COVID-19 (3 papers), interferon and immune responses (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Infectious Diseases (61 citations), Oncology (40 citations), Genetics (41 citations), Obstetrics and Gynecology (10 citations) and Immunology (28 citations). Emad Behboudi has collaborated with scholars based in Iran, United States and Türkiye. Frequent co-authors include Hassan Dianat‐Moghadam, Amir Ghaemi, Mohsen Nakhaie, Mohsen Keshavarz, Seyed Mohammad Miri, Javad Charostad, Mohammad Javad Mousavi, Milad Zandi, Shokrollah Salmanzadeh and Jila Yavarian. Their work appears in journals such as European Journal of Inflammation, Biotechnology and Applied Biochemistry, Library Hi Tech, Health Care For Women International and Advances in Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.